Ovarian toxicity: From environmental exposure to chemotherapy

Current Pharmaceutical Design

Volumn 20, Issue 34, 2014, Pages 5388-5397

  Iorio, Roberto ^a   Castellucci, Annalisa ^a   Ventriglia, Giovanni ^a   Teoli, Flavia ^a   Cellini, Valerio ^a   Macchiarelli, Guido ^a   Cecconi, Sandra ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

1 3 butadiene; 4 Vinylcycloexene; Chemotherapy; Mancozeb; Ovary; PHAs; Radiotherapy; Xenobiotics

Indexed keywords

1,3 BUTADIENE; 4 VINYLCYCLOEXENE; ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; AROMATIC HYDROCARBON RECEPTOR; CARCINOGEN; CISPLATIN; ENVIRONMENTAL CHEMICAL; MANCOZEB; POLYCYCLIC AROMATIC HYDROCARBON; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; XENOBIOTIC AGENT;

ARTICLE; BIOTRANSFORMATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DETOXIFICATION; ENVIRONMENTAL EXPOSURE; FEMALE; FEMALE INFERTILITY; HUMAN; LIFESPAN; METABOLIC ACTIVATION; METABOLIC DISORDER; MOLECULAR PATHOLOGY; NONHUMAN; OCCUPATIONAL CANCER; OCCUPATIONAL CARCINOGENESIS; OCCUPATIONAL TOXICOLOGY; OVARIAN TOXICITY; OVARY CANCER; OVARY DISEASE; PRIORITY JOURNAL; RADIATION INJURY; REPRODUCTIVE TOXICITY; SIGNAL TRANSDUCTION; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; OVARY; OVARY FOLLICLE; PREMATURE OVARIAN FAILURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOGENS, ENVIRONMENTAL; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; OVARIAN DISEASES; OVARIAN FOLLICLE; OVARY; PRIMARY OVARIAN INSUFFICIENCY; XENOBIOTICS;

EID: 84920260724     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140205145319     Document Type: Article

References (153)

1. [1] Baan R, Grosse Y, Straif K, et al. A review of human carcinogens-Part F: Chemical agents and related occupations. Lancet Oncol 2009; 10: 1143-4.
2. [2] Hunt PA, Hassold TJ. Human female meiosis: what makes a good egg go bad? Trends Genet 2008; 24(2): 86-93.
3. Selesniemi K, Lee HJ, Muhlhauser A, Tilly JL. Prevention of maternal aging-associated oocyte aneuploidy and meiotic spindle defects in mice by dietary and genetic strategies. Proc Natl Acad Sci USA 2011; 26: 108(30): 12319-24.
4. [4] Brann DW, Mahesh VB. The aging reproductive neuroendocrine axis. Steroids 2005; 70(4): 273-83.
5. [5] Canipari R, Cellini V, Cecconi S. The ovary feels fine when paracrine and autocrine networks cooperate with gonadotropins in the regulation of folliculogenesis. Curr Pharm Des 2012; 18(3): 245-55.
6. [6] Zuccotti M, Merico V, Cecconi S, Redi CA, Garagna S. What does it take to make a developmentally competent mammalian egg? Hum Reprod Update 2011; 17(4): 525-40.
7. [7] Cecconi S, Ciccarelli C, Barberi M, Macchiarelli G, Canipari R. Granulosa cell-oocyte interactions. Eur J Obstet Gynecol Reprod Biol 2004; 1: 115 Suppl 1: S19-22.
8. [8] Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocrine Reviews 2009; 30(6): 624-712.
9. [9] Hoyer PB, Sipes IG. Assessment of follicle destruction in chemical-induced ovarian toxicity. Annu Rev Pharmacol Toxicol 1996; 36: 307-31
10. [10] St Helen G, Dempsey D, Wilson M, Jacob P, Benowitz NL. Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure. Addiction 2013; 108(3): 607-17.
11. [11] Lodovici M, Akpan V, Evangelisti C, Dolara P. Sidestream tobacco smoke as the main predictor of exposure to polycyclic aromatic hydrocarbons. J Appl Toxicol 2004; 24(4): 277-81.
12. [12] Mastral AM, Callén MS, García T, Lopez JM. Benzo(a)pyrene, benzo(a)anthracene, and dibenzo(a,h)anthracene emissions from coal and waste tire energy generation at atmospheric fluidized bed combustion (AFBC). Environ Sci Technol 2001; 35(13): 2645-9.
13. [13] Hoyer PB, Davis JR, Bedrnicek JB, et al. Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure. Gynecol Oncol 2009; 112(3): 610-5.
14. [14] Craig ZR, Davis JR, Marion SL, Barton JK, Hoyer PB. 7,12-dimethylbenz[a]anthracene induces sertoli-leydig-cell tumors in the follicle-depleted ovaries of mice treated with 4-vinylcyclohexene diepoxide. Comp Med 2010; 60(1): 10-7.
15. [15] Lim J, Lawson GW, Nakamura BN, et al. Glutathione-deficient mice have increased sensitivity to transplacental benzo[a]pyreneinduced premature ovarian failure and ovarian tumorigenesis. Cancer Res 2013; 73(2): 908-17.
16. [16] Hughes EG, Brennan BG. Does cigarette smoking impair natural or assisted fecundity? Fertil Steril 1996; 66(5): 679-89.
17. Mattison DR. The effects of smoking on fertility from gametogenesis to implantation. Environ Res 1982; 28(2): 410-33. Review.
18. [18] Harlow BL, Signorello LB. Factors associated with early menopause. Maturitas 2000; 35: 3-9.
19. [19] Di Prospero F, Luzi S, Iacopini Z. Cigarette smoking damages women's reproductive life. Reprod Biomed Online 2004; 8(2): 246-7.
20. [20] Chang SH, Kim CS, Lee KS, et al. Premenopausal factors influencing premature ovarian failure and early menopause. Maturitas 2007; 58(1): 19-30.
21. [21] Augood C, Duckitt K, Templeton AA. Smoking and female infertility: a systematic review and meta-analysis. Hum Reprod 1998; 13(6): 1532-9.
22. [22] Zenzes MT. Smoking and reproduction: gene damage to human gametes and embryos. Hum Reprod Update 2000; 6(2): 122-31.
23. [23] Seltzer V. Smoking as a risk factor in the health of women. Int J Gynaecol Obstet 2003; 82(3): 393-7.
24. [24] Neal MS, Hughes EG, Holloway AC, Foster WG. Sidestream smoking is equally as damaging as mainstream smoking on IVF outcomes. Hum Reprod 2005; 20(9): 2531-5.
25. [25] Freour T, Masson D, Mirallie S, et al. Active smoking compromises IVF outcome and affects ovarian reserve. Reprod Biomed Online 2008; 16(1): 96-102.
26. Fréour T, Dessolle L, Lammers J, Lattes S, Barrière P. Comparison of embryo morphokinetics after in vitro fertilizationintracytoplasmic sperm injection in smoking and nonsmoking women. Fertil Steril 2013; Feb 25 (in press)
27. [27] Gruber I, Just A, Birner M, Lösch A. Effect of a woman's smoking status on oocyte, zygote, and day 3 pre-embryo quality in in vitro fertilization and embryo transfer program. Fertil Steril 2008; 90(4): 1249-52.
28. [28] Neal MS, Zhu J, Holloway AC, Foster WG. Follicle growth is inhibited by benzo-[a]-pyrene, at concentrations representative of human exposure, in an isolated rat follicle culture assay. Hum Reprod 2007; 22(4): 961-7.
29. [29] Neal MS, Zhu J, Foster WG. Quantification of benzo[a]pyrene and other PAHs in the serum and follicular fluid of smokers versus non-smokers. Reprod Toxicol 2008; 25(1): 100-6.
30. [30] Stedman RL. The chemical composition of tobacco and tobacco smoke. Chem Rev 1968; 68(2): 153-207.
31. [31] Borman SM, Christian PJ, Sipes IG, Hoyer PB. Ovotoxicity in female Fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarbons: comparison through calculation of an ovotoxic index. Toxicol Appl Pharmacol 2000; 167(3): 191-8.
32. [32] Rajapaksa KS, Sipes IG, Hoyer PB. Involvement of microsomal epoxide hydrolase enzyme in ovotoxicity caused by 7,12-dimethylbenz[a]anthracene. Toxicol Sci 2007; 96(2): 327-34.
33. [33] Igawa Y, Keating AF, Rajapaksa KS, Sipes IG, Hoyer PB. Evaluation of ovotoxicity induced by 7, 12-dimethylbenz[a]anthracene and its 3,4-diol metabolite utilizing a rat in vitro ovarian culture system. Toxicol Appl Pharmacol. 2009; 234(3): 361-9.
34. [34] Matikainen T, Perez GI, Jurisicova A, et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 2001; 28(4): 355-60.
35. [35] Carlson DB, Perdew GH. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J Biochem Mol Toxicol 2002; 16(6): 317-25.
36. [36] Petrulis JR, Perdew GH. The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem Biol Interact 2002; 141(1-2): 25-40.
37. [37] Pollenz RS, Sattler CA, Poland A. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by im munofluorescence microscopy. Mol Pharmacol 1994; 45(3): 428-38.
38. [38] Pocar P, Fischer B, Klonisch T, Hombach-Klonisch S. Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction 2005; 129(4): 379-89.
39. [39] Robles R, Morita Y, Mann KK, et al. The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse. Endocrinology 2000; 141(1): 450-3.
40. [40] Bussmann UA, Barañao JL. Regulation of aryl hydrocarbon receptor expression in rat granulosa cells. Biol Reprod 2006; 75(3): 360-9.
41. [41] Jurisicova A, Taniuchi A, Li H, et al. Maternal exposure to polycyclic aromatic hydrocarbons diminishes murine ovarian reserve via induction of Harakiri. J Clin Invest 2007; 117(12): 3971-8.
42. [42] Neal MS, Mulligan Tuttle AM, Casper RF, Lagunov A, Foster WG. Aryl hydrocarbon receptor antagonists attenuate the deleterious effects of benzo[a]pyrene on isolated rat follicle development. Reprod Biomed Online 2010; 21(1): 100-8.
43. [43] Sobinoff AP, Nixon B, Roman SD, McLaughlin EA. Staying alive: PI3K pathway promotes primordial follicle activation and survival in response to 3MC-induced ovotoxicity. Toxicol Sci 2012; 128(1): 258-71.
44. [44] Sobinoff AP, Pye V, Nixon B, Roman SD, McLaughlin EA. Jumping the gun: smoking constituent BaP causes premature primordial follicle activation and impairs oocyte fusibility through oxidative stress. Toxicol Appl Pharmacol 2012; 260(1): 70-80.
45. [45] Shiromizu K, Mattison DR. Murine oocyte destruction following intraovarian treatment with 3-methylcholanthrene or 7,12-dimethylbenz(a)anthracene: protection by alpha-naphthoflavone. Teratog Carcinog Mutagen 1985; 5(6): 463-72.
46. [46] Bhattacharya P, Keating AF. Protective role for ovarian glutathione S-transferase isoform pi during 7,12-dimethylbenz[a]anthraceneinduced ovotoxicity. Toxicol Appl Pharmacol 2012; 260(2): 201-8.
47. [47] Keating AF, J Mark C, Sen N, Sipes IG, Hoyer PB. Effect of phosphatidylinositol-3 kinase inhibition on ovotoxicity caused by 4-vinylcyclohexene diepoxide and 7, 12-dimethylbenz[a]anthracene in neonatal rat ovaries. Toxicol Appl Pharmacol 2009; 241(2): 127-34.
48. [48] Sobinoff AP, Mahony M, Nixon B, Roman SD, McLaughlin EA. Understanding the Villain: DMBA-induced preantral ovotoxicity involves selective follicular destruction and primordial follicle activation through PI3K/Akt and mTOR signaling. Toxicol Sci 2011; 123(2): 563-75.
49. [49] Shimada T, Sugie A, Shindo M, et al. Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of arylhydrocarbon receptor gene. Toxicol Appl Pharmacol 2003; 187(1): 1-10.
50. [50] Shimada T, Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 2004; 95(1): 1-6.
51. [51] Cannady EA, Dyer CA, Christian PJ, Sipes IG, Hoyer PB. Expression and activity of microsomal epoxide hydrolase in follicles isolated from mouse ovaries. Toxicol Sci 2002; 68(1): 24-31.
52. [52] Buters J, Quintanilla-Martinez L, Schober W, et al. CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicity. Carcinogenesis 2003; 24(2): 327-34.
53. [53] Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 2009; 41(2): 89-295.
54. [54] Tsai-Turton M, Nakamura BN, Luderer U. Induction of apoptosis by 9,10-dimethyl-1,2-benzanthracene in cultured preovulatory rat follicles is preceded by a rise in reactive oxygen species and is prevented by glutathione. Biol Reprod 2007; 77(3): 442-51.
55. [55] Hausbeck MK. Pest management in the future. A Strategic Plan for the Michigan and Wisconsin. Ginseng Industry Workshop Summary; 2010 December 6, Courtyard Grand Rapids Downtown, Grand Rapids, Michigan
56. [56] Axelstad M, Boberg J, Nellemann C, et al. Exposure to the widely used fungicide mancozeb causes thyroid hormone disruption in rat dams but no behavioral effects in the offspring. Toxicol Sci 2011; 120(2): 439-46.
57. [57] Nordby KC, Andersen A, Irgens LM, Kristensen P. Indicators of mancozeb exposure in relation to thyroid cancer and neural tube defects in farmers' families. Scand J Work Environ Health 2005; 31(2): 89-96.
58. [58] Hurley PM. Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environ Health Perspect 1998; 106(8): 437-45.
59. [59] Kackar R, Srivastava MK, Raizada RB. Studies on rat thyroid after oral administration of mancozeb: morphological and biochemical evaluations. J Appl Toxicol 1997; 17(6): 369-75.
60. [60] Belpoggi F, Soffritti M, Guarino M, Lambertini L, Cevolani D, Maltoni C. Results of long-term experimental studies on the carcinogenicity of ethylene-bis-dithiocarbamate (Mancozeb) in rats. Ann N Y Acad Sci. 2002; 982: 123-36.
61. [61] Cecconi S, Paro R, Rossi G, Macchiarelli G. The effects of the endocrine disruptors dithiocarbamates on the mammalian ovary with particular regard to mancozeb. Curr Pharm Des 2007; 13(29): 2989-3004.
62. [62] Tyagi S, George J, Singh R, Bhui K, Shukla Y. Neoplastic alterations induced in mammalian skin following mancozeb exposure using in vivo and in vitro models. OMICS 2011; 15(3): 155-67.
63. [63] Shukla Y, Arora A. Transplacental carcinogenic potential of the carbamate fungicide mancozeb. J Environ Pathol Toxicol Oncol 2001; 20(2): 127-31.
64. [64] Srivastava AK, Ali W, Singh R, et al. Mancozeb-induced genotoxicity and apoptosis in cultured human lymphocytes. Life Sci 2012; 90(21-22): 815-24.
65. [65] Mahadevaswami MP, Jadaramkunti UC, Hiremath MB, Kaliwal BB. Effect of mancozeb on ovarian compensatory hypertrophy and biochemical constituents in hemicastrated albino rat. Reprod Toxicol 2000; 14(2): 127-34.
66. [66] Baligar PN, Kaliwal BB. Induction of gonadal toxicity to female rats after chronic exposure to mancozeb. Ind Health 2001; 39(3): 235-43.
67. [67] Baligar PN, Kaliwal BB. Morphometric analysis of follicular growth and biochemical constituents in albino rats exposed to mancozeb. J Basic Clin Physiol Pharmacol 2004; 15(3-4): 241-62.
68. [68] Rossi G, Buccione R, Baldassarre M, Macchiarelli G, Palmerini MG, Cecconi S. Mancozeb exposure in vivo impairs mouse oocyte fertilizability. Reprod Toxicol 2006; 21(2): 216-9.
69. [69] Rossi G, Palmerini MG, Macchiarelli G, Buccione R, Cecconi S. Mancozeb adversely affects meiotic spindle organization and fertilization in mouse oocytes. Reprod Toxicol 2006; 22(1): 51-5.
70. [70] Greenlee AR, Ellis TM, Berg RL. Low-dose agrochemicals and lawn-care pesticides induce developmental toxicity in murine preimplantation embryos. Environ Health Perspect 2004; 112(6): 703-9.
71. [71] Paro R, Tiboni GM, Buccione R, et al. The fungicide mancozeb induces toxic effects on mammalian granulosa cells. Toxicol Appl Pharmacol 2012; 260(2): 155-61.
72. [72] NTP (National Toxicology Program). National Toxicology Program, Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies). Natl Toxicol Program Tech Rep Ser 1984; 288: 1-111.
73. [73] NTP (National Toxicology Program). National Toxicology Program, Toxicology and Carcinogenesis Studies of 4-Vinylcyclohexene (CAS No. 100-40-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 1986; 303: 1-190.
74. Huff J. Carcinogenicity bioassays of bisphenol A, 4-vinylcyclohexene diepoxide, and 4-vinycyclohexene. Toxicol Sci 2001 Dec; 64(2): 282-3; author reply 284.
75. [75] Cheng H, Sathiakumar N, Graff J, Matthews R, Delzell E. 1,3-Butadiene and leukemia among synthetic rubber industry workers: exposure-response relationships. Chem Biol Interact 2007; 166(1-3): 15-24.
76. Delzell E, Sathiakumar N, Graff J, Macaluso M, Maldonado G, Matthews R. Health Effects Institute. An updated study of mortality among North American synthetic rubber industry workers. Res Rep Health Eff Inst 2006; (132): 1-63; discussion 65-74.
77. [77] Graff JJ, Sathiakumar N, Macaluso M, Maldonado G, Matthews R, Delzell E. Chemical exposures in the synthetic rubber industry and lymphohematopoietic cancer mortality. J Occup Environ Med 2005; 47(9): 916-32.
78. [78] Hecht SS. Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen 2002; 39(2-3): 119-26.
79. [79] Grant RL, Haney J, Curry AL, Honeycutt M. A chronic reference value for 1,3-butadiene based on an updated noncancer toxicity assessment. J Toxicol Environ Health B Crit Rev 2010; 13(6): 460-75.
80. [80] Owen PE, Glaister JR, Gaunt IF, Pullinger DH. Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats. Am Ind Hyg Assoc J 1987; 48(5): 407-13.
81. [81] NTP (National Toxicology Program). National Toxicology Program, 9th Report on Carcinogens, 1,3-Butadiene CAS No. 106-99-0, U.S. Department of Health and Human Services, Public Health Service 2001.
82. [82] Seaton MJ, Follansbee MH, Bond JA. Oxidation of 1,2-epoxy-3-butene to 1,2: 3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 1995; 16(10): 2287-93.
83. [83] Doerr JK, Hollis EA, Sipes IG. Species difference in the ovarian toxicity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague-Dawley rats. Toxicology 1996; 113(1-3): 128-36.
84. IARC. 4-Vinylcyclohexene. IARC monographs on the evaluation of carcinogenic risks to humans: Some industrial chemicals. 60: 347-59
85. [85] Smith BJ, Mattison DR, Sipes IG. The role of epoxidation in 4-vinylcyclohexene-induced ovarian toxicity. Toxicol Appl Pharmacol 1990; 105(3): 372-81.
86. [86] Hooser SB, Douds DP, DeMerell DG, Hoyer PB, Sipes IG. Longterm ovarian and gonadotropin changes in mice exposed to 4-vinylcyclohexene. Reprod Toxicol 1994; 8(4): 315-23.
87. [87] Doerr JK, Hooser SB, Smith BJ, Sipes IG. Ovarian toxicity of 4-vinylcyclohexene and related olefins in B6C3F1 mice: role of diepoxides. Chem Res Toxicol 1995; 8(7): 963-9.
88. [88] Flaws JA, Doerr JK, Sipes IG, Hoyer PB. Destruction of preantral follicles in adult rats by 4-vinyl-1-cyclohexene diepoxide. Reprod Toxicol 1994; 8: 509-14
89. [89] Springer LN, Tilly JL, Sipes IG, Hoyer PB. Enhanced expression of bax in small preantral follicles during 4-vinylcyclohexene diepoxide-induced ovotoxicity in the rat. Toxicol Appl Pharmacol 1996; 139(2): 402-10.
90. [90] Springer LN, McAsey ME, Flaws JA, Tilly JL, Sipes IG, Hoyer PB. Involvement of apoptosis in 4-vinylcyclohexene diepoxideinduced ovotoxicity in rats. Toxicol Appl Pharmacol 1996; 139(2): 394-401.
91. [91] Hu X, Christian P, Sipes IG, Hoyer PB. Expression and redistribution of cellular Bad, Bax, and Bcl-X(L) protein is associated with VCD-induced ovotoxicity in rats. Biol Reprod 2001; 65(5): 1489-95.
92. [92] Hu X, Christian PJ, Thompson KE, Sipes IG, Hoyer PB. Apoptosis induced in rats by 4-vinylcyclohexene diepoxide is associated with activation of the caspase cascades. Biol Reprod 2001; 65(1): 87-93.
93. [93] Hu X, Flaws JA, Sipes IG, Hoyer PB. Activation of mitogenactivated protein kinases and AP-1 transcription factor in ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats. Biol Reprod 2002; 67(3): 718-24.
94. [94] Cannady EA, Dyer CA, Christian PJ, Sipes IG, Hoyer PB. Expression and activity of cytochromes P450 2E1, 2A, and 2B in the mouse ovary: the effect of 4-vinylcyclohexene and its diepoxide metabolite. Toxicol Sci 2003; 73(2): 423-30.
95. [95] Rajapaksa KS, Cannady EA, Sipes IG, Hoyer PB. Involvement of CYP 2E1 enzyme in ovotoxicity caused by 4-vinylcyclohexene and its metabolites. Toxicol Appl Pharmacol 2007; 221(2): 215-21.
96. [96] Bhattacharya P, Sen N, Hoyer PB, Keating AF. Ovarian expressed microsomal epoxide hydrolase: role in detoxification of 4-vinylcyclohexene diepoxide and regulation by phosphatidylinositol-3 kinase signaling. Toxicol Appl Pharmacol 2012; 258(1): 118-23.
97. [97] Keating AF, Sipes IG, Hoyer PB. Expression of ovarian microsomal epoxide hydrolase and glutathione S-transferase during onset of VCD-induced ovotoxicity in B6C3F(1) mice. Toxicol Appl Pharmacol 2008; 230(1): 109-16.
98. [98] Keating AF, Sen N, Sipes IG, Hoyer PB. Dual protective role for glutathione S-transferase class pi against VCD-induced ovotoxicity in the rat ovary. Toxicol Appl Pharmacol 2010; 247(2): 71-5.
99. [99] Bhattacharya P, Madden JA, Sen N, Hoyer PB, Keating AF. Glutathione S-transferase class _ regulation of apoptosis signalregulating kinase 1 protein during VCD-induced ovotoxicity in neonatal rat ovaries. Toxicol Appl Pharmacol 2013; 267(1): 49-56.
100. [100] Mark-Kappeler CJ, Sen N, Lukefahr A, et al. Inhibition of ovarian KIT phosphorylation by the ovotoxicant 4-vinylcyclohexene diepoxide in rats. Biol Reprod 2011; 85(4): 755-62.
101. [101] Fernandez SM, Keating AF, Christian PJ, et al. Involvement of the KIT/KITL signaling pathway in 4-vinylcyclohexene diepoxideinduced ovarian follicle loss in rats. Biol Reprod 2008; 79(2): 318-27.
102. [102] Liu K, Rajareddy S, Liu L, et al. Control of mammalian oocyte growth and early follicular development by the oocyte PI3 kinase pathway: new roles for an old timer. Dev Biol 2006; 299(1): 1-11.
103. [103] Cecconi S, Mauro A, Cellini V, Patacchiola F. The role of Akt signalling in the mammalian ovary. Int J Dev Biol 2012; 56(10-12): 809-17.
104. [104] Keating AF, Fernandez SM, Mark-Kappeler CJ, Sen N, Sipes IG, Hoyer PB. Inhibition of PIK3 signaling pathway members by the ovotoxicant 4-vinylcyclohexene diepoxide in rats. Biol Reprod 2011; 84(4): 743-51.
105. [105] Muhammad FS, Goode AK, Kock ND, et al. Effects of 4-vinylcyclohexene diepoxide on peripubertal and adult Sprague-Dawley rats: ovarian, clinical, and pathologic outcomes. Comp Med 2009; 59(1): 46-59.
106. [106] Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7(6): 535-43.
107. [107] Ataya K, Pydyn E, Ramahi-Ataya A, Orton CG. Is radiationinduced ovarian failure in rhesus monkeys preventable by luteinizing hormone-releasing hormone agonists?: Preliminary observations. J Clin Endocrinol Metab 1995; 80(3): 790-5.
108. [108] Lee CJ, Park HH, Do BR, Yoon Y, Kim JK. Natural and radiationinduced degeneration of primordial and primary follicles in mouse ovary. Anim Reprod Sci 2000; 59(1-2): 109-17.
109. [109] Devine PJ, Perreault SD, Luderer U. Roles of reactive oxygen species and antioxidants in ovarian toxicity. Biol Reprod 2012; 86(2): 27.
110. [110] Adriaens I, Smitz J, Jacquet P. The current knowledge on radiosensitivity of ovarian follicle development stages. Hum Reprod Update 2009; 15(3): 359-77.
111. [111] Datta K, Suman S, Kallakury BV, Fornace AJ Jr. Exposure to heavy ion radiation induces persistent oxidative stress in mouse intestine. PLoS One 2012; 7(8): e42224.
112. [112] Said RS, Nada AS, El-Demerdash E. Sodium selenite improves folliculogenesis in radiation-induced ovarian failure: a mechanistic approach. PLoS One 2012; 7(12): e50928.
113. [113] Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 2009; 73(5): 1304-12.
114. [114] Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 2006; 98(13): 890-6.
115. [115] Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005; 62(3): 738-44.
116. [116] Bath LE, Anderson RA, Critchley HO, Kelnar CJ, Wallace WH. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum Reprod 2001; 16(9): 1838-44.
117. [117] McLaren JF, Bates GW. Fertility preservation in women of reproductive age with cancer. Am J Obstet Gynecol 2012; 207(6): 455-62.
118. [118] Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol 2009; 36(3): 237-49.
119. [119] Binaschi M, Bigioni M, Cipollone A, et al. Anthracyclines: selected new developments. Curr Med Chem Anticancer Agents 2001; 1(2): 113-30.
120. [120] Cortés-Funes H, Coronado C. Role of anthracyclines in the era of targeted therapy. Cardiovasc Toxicol 2007; 7(2): 56-60.
121. [121] Tokarska-Schlattner M, Zaugg M, Zuppinger C, Wallimann T, Schlattner U. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics. J Mol Cell Cardiol 2006; 41(3): 389-405.
122. [122] Green PS, Leeuwenburgh C. Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis. Biochim Biophys Acta 2002; 1588(1): 94-101.
123. [123] Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 2005; 115(10): 2656-64.
124. [124] Brougham MF, Crofton PM, Johnson EJ, Evans N, Anderson RA, Wallace WH. Anti-Müllerian hormone is a marker of gonadotoxicity in pre-and postpubertal girls treated for cancer: a prospective study. J Clin Endocrinol Metab 2012; 97(6): 2059-67.
125. [125] Harel S, Fermé C, Poirot C. Management of fertility in patients treated for Hodgkin's lymphoma. Haematologica 2011 Nov; 96(11): 1692-9
126. [126] Ben-Aharon I, Bar-Joseph H, Tzarfaty G, et al. Doxorubicininduced ovarian toxicity. Reprod Biol Endocrinol 2010; 8: 20.
127. [127] Roti Roti EC, Leisman SK, Abbott DH, Salih SM. Acute doxorubicin insult in the mouse ovary is cell-and follicle-type dependent. PLoS One 2012; 7(8): e42293.
128. [128] Bar-Joseph H, Ben-Aharon I, Rizel S, Stemmer SM, Tzabari M, Shalgi R. Doxorubicin induced apoptosis in germinal vesicle (GV) oocytes. Reprod Toxicol 2010; 30(4): 566-72.
129. [129] Soleimani R, Heytens E, Darzynkiewicz Z, Oktay K. Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise. Aging (Albany NY) 2011 Aug; 3(8): 782-93.
130. [130] Bar-Joseph H, Ben-Aharon I, Tzabari M, Tsarfaty G, Stemmer SM, Shalgi R. In vivo bioimaging as a novel strategy to detect doxorubicin-induced damage to gonadal blood vessels. PLoS One 2011; 6(9): e23492.
131. [131] Roti Roti EC, Salih SM. Dexrazoxane ameliorates doxorubicininduced injury in mouse ovarian cells. Biol Reprod 2012; 86(3): 96.
132. [132] Bezler M, Hengstler JG, Ullrich A Inhibition of doxorubicininduced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells. Mol Oncol 2012; 6(5): 516-29.
133. [133] Yoshimoto K, Mizoguchi M, Hata N, et al. Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma. Front Oncol 2012; 2: 186.
134. [134] Clowse ME, Harward L, Criscione-Schreiber L, Pisetsky D, Copland S. Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide. Arthritis Rheum 2012; 64(5): 1305-10
135. [135] van der Kaaij MA, Heutte N, Meijnders P, et al. Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study. J Clin Oncol 2012; 30(3): 291-9.
136. [136] Kishk EA, Mohammed Ali MH. Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice. Arch Gynecol Obstet 2013; 287(5): 1023-9.
137. [137] Maman E, Prokopis K, Levron J, Carmely A, Dor J, Meirow D. Does controlled ovarian stimulation prior to chemotherapy increase primordial follicle loss and diminish ovarian reserve? An animal study. Hum Reprod 2009; 24(1): 206-10.
138. [138] Meirow D, Dor J, Kaufman B, et al. Cortical fibrosis and bloodvessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod 2007; 22(6): 1626-33.
139. [139] Lopez SG, Luderer U. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis. Free Radic Biol Med 2004; 36(11): 1366-77.
140. [140] Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998; 34(10): 1522-34.
141. [141] Kim JH, Park SG, Song SY, Kim JK, Sung JH. Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2. Cell Death Dis 2013; 4: e588.
142. [142] Gonfloni S, Di Tella L, Caldarola S, et al. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapyinduced death. Nat Med 2009; 15(10): 1179-85.
143. [143] Kim BK, Lee SC, Kim KJ, Han CH, Kim JH. In vitro maturation, fertilization, and development of human germinal vesicle oocytes collected from stimulated cycles. Fertil Steril 2000; 74(6): 1153-8.
144. [144] Yeh J, Kim BS, Peresie J, Page C. Declines in levels of hyperpolarization-activated cation (HCN) channels in the rat ovary after cisplatin exposure. Reprod Sci 2009; 16(10): 986-94.
145. [145] Li X, Kang X, Deng Q, Cai J, Wang Z. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study. Reprod Biol Endocrinol 2013 Mar 1; 11: 16.
146. [146] Ting AY, Petroff BK. Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat. J Assist Reprod Genet 2010; 27(11): 591-7.
147. [147] Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004 Mar 11; 428(6979): 145-50.
148. [148] White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med 2012; 18(3): 413-21.
149. [149] Dunlop CE, Telfer EE, Anderson RA. Ovarian stem cells-Potential roles in infertility treatment and fertility preservation. Maturitas 2013 May 18.
150. [150] Telfer EE, Gosden RG, Byskov AG, et al. On regenerating the ovary and generating controversy. Cell 2005 Sep 23; 122(6): 821-2.
151. [151] Byskov AG, Faddy MJ, Lemmen JG, Andersen CY. Eggs forever? Differentiation 2005; 73(9-10): 438-46.
152. [152] Tilly JL, Niikura Y, Rueda BR. The current status of evidence for and against postnatal oogenesis in mammals: a case of ovarian optimism versus pessimism? Biol Reprod 2009; 80(1): 2-12.
153. [153] Kerr JB, Brogan L, Myers M, et al. The primordial follicle reserve is not renewed after chemical or _-irradiation mediated depletion. Reproduction 2012; 143(4): 469-76.